Keystone Bio has identified and is targeting a "one of a kind Inflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.Keystone Bio is a nextgen PharmaBiome biotech that has identified and is targeting a "one of a kindInflammapath ", the keystone pathogen of chronic inflammation that’s been shown to initiate and advance Atherosclerosis, Heart disease and Alzheimer's disease.

Biotechnology

Health Care

Pharmaceutical

Keystone Bio

Daniel Sindelar DMD

Peter Nara

Jim Klein

Michael Rafii

Marc Penn

Advisory Team

Leadership Team

Keystone Bio

Org chart

Teams

Advisory Team

Leadership Team

Similar companies